VAGINAL MICROBIOCENOSIS AND CERVICAL PATHOLOGY
Keywords:
vaginal microbiome, bacterial vaginosis, Gardnerella vaginalis, Lactobacillus, female healthAbstract
The vaginal microbiome is an intricate and dynamic microecosystem that constantly undergoes fluctuations during the female menstrual cycle and the woman’s entire life. A healthy vaginal microbiome is dominated by Lactobacillus which produce various antimicrobial compounds. Bacterial vaginosis (BV) is characterized by the loss or sharp decline in the total number of Lactobacillus and a corresponding marked increase in the concentration of anaerobic microbes. BV is a highly prevalent disorder of the vaginal microbiota among women of reproductive age globally.
References
Polonskaya N.Yu., Rogovskaya S.I. Anatomy and physiology of the cervix, vagina, vulva. In the book: Cervix, vagina, vulva. A guide for practicing physicians. Edited by S.I.Rogovskaya, E.V.Lipova. Moscow: Status Presents, 2014.
Shulzhenko A.E., Zuikova I.N. Persistent papillomavirus infection: cytokine imbalance and approaches to therapy. Effective pharmacotherapy. Obstetrics and gynecology. 2013; 2 (18).
Rogovskaya SI, Shabalova IP, Mikheeva IV et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the Former Soviet Union, Caucasus region and Central Asia. Vaccine 2013; 31S: H46–58.
Kira E.F., Muslimova S.Z. Nonspecific vaginitis and its effect on women's reproductive health (literature review). St. Petersburg, 2001.
Radzinsky V.E. Bacterial vaginosis. In the book: Cervix, vagina, vulva. A guide for practicing physicians. Edited by S.I.Rogovskaya, E.V.Lipova. Moscow: Status Presents, 2014.
Rogovskaya S.I., Bebneva T.N. Benign diseases of the cervix. In the book: Cervix, vagina, vulva. A guide for practicing physicians. Edited by S.I.Rogovskaya, E.V.Lipova. Moscow: Status Presents, 2014.
Ankirskaya A.S. Nonspecific vaginitis. Gynecology. 2005; 4: 15-8.
Tikhomirov A.L. Bacterial vaginosis. Are there always and only antibiotics? Cons. Med. 2011; 13 (6): 52–5.
Swidsinski A, Mendling W, Loening-Baucke V et al. Adherent biofilms in bacterial vaginosis. Am J Obstet Gynecol 2008; 198: 97.е1–97.
Sobel JD. Vaginitis in adult women. Obstet Gynecol Clin North Am 2009; 17 (4): 851–79.
Гомберг М.А. Европейские стандарты ведения женщин с ИППП. В кн.: Шейка матки, влагалище, вульва. Руководство для практикующих врачей. Под ред. С.И.Роговской, Е.В.Липовой. М.: Статус Презенс, 2014.
Bradshaw CS, Tabrizi SN, Fairleyetal CK. Theassociation of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 2006; 194 (6): 828–36.
www.cdc.org
Petersen EE, Genet M, Caserini M, Palmieri R. Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled study. Arzneimittelforschung 2011; 61 (4): 260–5.
Huang H et al. Effects of probiotics for the treatment of bacterial vaginosis in adult women: A meta-analysis of randomized clinical trials Arch Gynecol Obstet 12.19.2013.
An D, Parsek MR. The promise and peril of transcriptional profiling in biofilm communities. Curr Opin Microbiol 2007; 10 (3): 292–6.
Yoshimura K, Morotomi N, Fukuda K et al. Intravaginal microbial flora by the 16S rRNA gene sequencing. Am J Obstet Gynecol 2011; 205 (3): e1–9.
Буданов П.В. и др. Вопр. гинекологии, акушерства и перинатологии. 2012; 11 (2): 58-62.
Громова О.А. и др. Молекулярные механизмы разрушения бактериальных пленок при топическом применении аскорбиновой кислоты. Гинекология. 2012; 12 (6): 36–41.
Sherrard J, Donders G, White D. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge, 2011.





